How Amgen Delivered a New Rare Disease Therapy
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
False
June 2, 2025
We speak with experts from Amgen and Henry Ford Health about the development and approval of Uplizna for IgG4-related disease.
9 min read
By Stephanie Vine
June 2, 2025
Patient fatality reported in clinical trial for investigational gene therapy for Danon disease
2 min read
May 28, 2025
Researchers conduct small phase I study on the potential of placenta-derived stem cell therapy to treat a serious form of MS with limited therapeutic options
2 min read
May 27, 2025
The industry has spent decades optimizing distribution strategies to meet faster timelines. Now, it’s time to think about sustainability.
7 min read
May 12, 2025
Can digital tools help lower the carbon footprint of a clinical trial? First, we need more data.
5 min read
By Stephanie Vine
May 7, 2025
Gene therapy clinical trial shows striking outcomes in children with rare and often fatal immune disorder
2 min read
May 6, 2025
Can making clinical trials more family friendly help increase the number of female participants?
4 min read
By Stephanie Vine
May 1, 2025
Our latest news roundup reports on Amgen’s $900 million investment, EMA’s re-examination of donanemab, philanthropy at Sanofi, and more
3 min read
By Stephanie Vine
April 29, 2025
Non-clinical toxicology study reveals worrying results
1 min read
By Rob Ellison
March 31, 2025
An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.
7 min read
False
False
False